SC, H., TC, K., IE, v. d. H., O, K., VP, v. H., HACM, d. B., . . . MT, N. (2018). The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis. Dove Medical Press.
Chicago Style (17th ed.) CitationSC, Heslinga, Konings TC, van der Horst-Bruinsma IE, Kamp O, van Halm VP, de Bruin-Bon HACM, Peters MJ, and Nurmohamed MT. The Effects of Golimumab Treatment on Systolic and Diastolic Left Ventricular Function in Ankylosing Spondylitis. Dove Medical Press, 2018.
MLA (8th ed.) CitationSC, Heslinga, et al. The Effects of Golimumab Treatment on Systolic and Diastolic Left Ventricular Function in Ankylosing Spondylitis. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.